Yaxuan Liu

Ms. Yaxuan Liu

Carnegie Mellon University, Pittsburgh, Pennsylvania, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2022 in Insects
Verified
Journal Article
Open access
PDF file
YWYiyang Wu
Yiyang Wu
Yaxuan LiuYaxuan Liu
Yaxuan Liu
JYJinyong Yu
Jinyong Yu
YXYijuan Xu
Yijuan Xu
SCSiqi Chen
Siqi Chen
Observations have shown that seeds collected by harvester ants are less likely to mold. Based on evolutionary analysis and other research, it was hypothesized that harvester ants could apply actinomycetes to protect seeds, similar to the protection of mutualistic fungi by leafcutter ants. Two actinomycetes were successfully isolated from the harvester ant Messor orientalis. The taxonomic status of the actinomycetes was determined by 16S rRNA sequence analysis and biochemical experimental observations. Their inhibitory effects on plant pathogens were measured. One of the bacteria was identified as Brachybacterium phenoliresistens and denoted as B. phenoliresistens MO. The other belonged to the genus Microbacterium. It was named Microbacterium sp. Growth rate determination and coculture experiments were performed to explore the inhibitory effect of actinomycetes on indicator plant pathogens. The inhibition rates of the actinomycetes toward Peronophythora litchii and Rhizoctonia solani were 100% in media containing 30% or more fermentation broth, and they also showed an inhibitory effect on Colletotrichum siamense. The coculture experiment supported this result by showing that the growth of P. litchii and R. solani was inhibited in the presence of actinomycetes. Therefore, the results of this study show the agricultural application potential of these bacteria and may provide a reference for research on the symbiosis of harvester ants with actinomycetes.

1 March 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
FLFrank Y.C. Liu
Frank Y.C. Liu
Yaxuan LiuYaxuan Liu
Yaxuan Liu
XYXiu Yao
Xiu Yao
BWBoxiang Wang
Boxiang Wang

19 March 2025 in Carbon
Verified
Journal Article
Open access
MWMichelle E. Wolf
Michelle E. Wolf
WVWalker M. Vickery
Walker M. Vickery
WSWyatt Swift-Ramirez
Wyatt Swift-Ramirez
AAAnne Arnold
Anne Arnold
JOJason D. Orlando
Jason D. Orlando
SSStefanie A. Sydlik
Stefanie A. Sydlik

11 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ZCZiheng Chen
Ziheng Chen
Yaxuan LiuYaxuan Liu
Yaxuan Liu
ABAshley R. Brown
Ashley R. Brown
HSHeather H. Sestili
Heather H. Sestili
EREaswaran Ramamurthy
Easwaran Ramamurthy
APAndreas Theo Pfenning
Andreas Theo Pfenning
Noncoding genetic variants underlie many complex diseases, yet identifying and interpreting their functional impacts remains challenging. Late-onset Alzheimer’s disease (LOAD), a polygenic neurodegenerative disorder, exemplifies this challenge. The disease is strongly associated with noncoding variation, including common variants enriched in microglial enhancers and rare variants that are hypothesized to influence neurodevelopment and synaptic plasticity. These variants often perturb regulatory sequences by disrupting transcription factor (TF) motifs or altering local TF interactions, thereby reshaping gene expression and chromatin accessibility. However, assessing their impact is complicated by the context-dependent functions of regulatory sequences, underscoring the need to systematically examine variant effects across diverse tissues, cell types, and cellular states. Here, we combined in vitro and in vivo massively parallel reporter assays (MPRAs) with interpretable machine-learning models to systematically characterize common and rare variants across myeloid and neural contexts. Parallel profiling of variants in four immune states in vitro and three mouse brain regions in vivo revealed that individual variants can differentially and even oppositely modulate regulatory function depending on cell-type and cell-state contexts. Common variants associated with LOAD tended to exert stronger effects in immune contexts, whereas rare variants showed more pronounced impacts in brain contexts. Interpretable sequence-to-function deep-learning models elucidated how genetic variation leads to cell-type-specific differences in regulatory activity, pinpointing both direct transcription-factor motif disruptions and subtler tuning of motif context. To probe the broader functional consequences of a locus prioritized by our reporter assays and models, we used CRISPR interference to silence an enhancer within the SEC63-OSTM1 locus that harbors four functional rare variants, revealing its gatekeeper role in inflammation and amyloidogenesis. These findings underscore the context-dependent nature of noncoding variant effects in LOAD and provide a generalizable framework for the mechanistic interpretation of risk alleles in complex diseases.

21 May 2025 in ChemBioChem
Verified
Journal Article
Open access
MWMichelle E. Wolf
Michelle E. Wolf
Yaxuan LiuYaxuan Liu
Yaxuan Liu
JOJason D. Orlando
Jason D. Orlando
JZJingzhi Zhou
Jingzhi Zhou
SSStefanie A. Sydlik
Stefanie A. Sydlik
Traumatic bone injury is one of the most common injuries that require surgical intervention, and current treatments suffer severe drawbacks. Modern research in bone regeneration focuses on implants that will support and enhance native tissue regeneration. One scaffold material that shows promise is graphene oxide (GO), a 2D nanomaterial made from oxidation of graphite. GO is biocompatible, strong, osteoinductive, is safely and slowly resorbed by the body, has a cheap, facile, and scalable synthesis, and is highly tailorable and functionalizable. The bioactivity of GO can be enhanced via functionalization with biomolecules such as peptides, proteins, and small molecules. Here, short peptides RGD, DGEA, and KKGHK are covalently bound to GO through a Claisen modification (CG) to create new functional graphenic materials that are cell‐adhesive, osteogenic, and angiogenic, respectively. These peptide‐Claisen graphenes (peptide‐CGs) are found to be cytocompatible, to encourage cell spreading on the graphenic surface, to promote osteogenesis in stem cells, and to induce angiogenesis in vascular endothelial cells. They show promise as next‐generation bone regeneration scaffolds by overcoming challenges frequently faced by bone regeneration scaffolds, namely retaining implanted and recruited cells, promoting their survival, proliferation, and differentiation, and ensuring a sufficient oxygen and nutrient supply to new tissue.